Health Condition 1: 4- Measurement and Monitoring
Conditions
Interventions
Intervention1: BUPIVACAINE: EPIDURAL INFUSION OF 0.125%/CC BUPIVACAINE FOR 24 HRS POST OP PERIOD.
Control Intervention1: DEXMEDETOMEDINE: AS EPIDURAL INFUSION 1MCG /KG ALONG WITH 0.125%/CC BUPIVACAINE
Sponsors
ACS MEDICAL COLLEGE AND HOSPITAL
Eligibility
Inclusion criteria
Inclusion criteria: ALL PATIENTS WILLING FOR STUDY. PATIENTS WITH BOTH GENDERS PATIENTS WHO ARE CONSIOUS AND ORIENTED ALL PATIENTS UNDERGOING SURGERIES BELOW LEVEL OF UMBILICUS ALL PATIENTS UNDER ASA 1, ASA 2, ASA 3 CATEGORIES, ALL PATIENTS UNDERGOING SURGERIES WITH SOLO EPIDURAL PROCEDURE, EPIDURAL WITH SPINAL WITH SPINAL DRUG WITH NO ADJUVANTS ,
Exclusion criteria
Exclusion criteria: PATIENTS WHO REFUSE FOR PROSEDURE PREGNANT PATIENTS PATIENTS WITH SPINAL BIRTH DEFECTS,HEMATOLOGICAL CONDITIONS ,HEMOSTATIC DISORDERS OBESE PATIENTS PATIENTS WITH CHRONIC BACK PAIN PSYCHIATRIC PATIENTS UNCONSIOUS,NOT ORIENTED,COMATOSED PATIENTS.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) HAEMODYNAMIC AND RESPIRATORY PARAMETERS ( BP,PULSE,SPO2,MAP) 2) VISUAL ANALOGUE PAIN SCORE MONITORING DURING PROCEDURE (VAS SCORE 1 TO 10)Timepoint: 1.at beginning of epidural infusion 2.at 5 min after first dose 3.at 10 min after beginning infusion 4.at 20 min after beginning of infusion 5.at 1hr after beginning of infusion 6.at 6hrs after beginning of infusion 7.at 12 hrs after beginning of infusion 8.at 24hrs after beginning of infusion | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) DOSE OF DRUG AT WHICH PATIENT GETS MAXIMUM PAIN RELIEF.Timepoint: DURING THE PROCEDURE | — |
Countries
India
Contacts
Public ContactDR RAMA
ACS MEDICAL COLLEGE AND HOSPITAL
Outcome results
None listed